Greatbatch completes acquisition of Enpath Medical

By Lisa Kerner

Charlotte, N.C., June 18 - Greatbatch, Inc. said it completed the acquisition of Enpath Medical, Inc. first announced on April 30, making Enpath a wholly owned, indirect subsidiary of Greatbatch.

The merger transaction was valued at $102 million, including debt.

Greatbatch acquired 5,790,211 shares, or 90.1%, of Enpath's stock in a $14.38-per-share tender offer ended June 5.

Enpath is a Minneapolis medical products company specializing in products for the cardiac rhythm management, neuromodulation and interventional radiology markets.

Greatbatch, based in Clarence, N.Y., develops and manufactures critical components used in implantable medical devices and other applications.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.